Bloomberg Billionaires Index

View profiles for each of the world’s 500 richest people, see the biggest movers, and compare fortunes or track returns.

# 448 Zhao Yan $5.41B

Random fact: Awarded an EY entrepreneur of the year award in 2016.


Zhao is the chairman and president of Bloomage Biotechnology, a maker of medical skincare products. The Jinan, China-based company is publicly traded and reported revenue of 4.9 billion yuan ($767 million) in 2021. Its products include hyaluronic acid, which is used by dermatologists to improve skin hydration.

As of :
Last change -$28.3M ( -0.5%)
YTD change -$1.01B ( -15.8%)
Biggest asset 688363 CH Equity
Country / Region China
Age 56
Industry Health Care
View net worth over:   Max 1 year 1 quarter 1 month 1 week

Relative Value

Zhao Yan's net worth of $5.41B can buy ...

troy ounces of gold
barrels of crude oil

... and is equivalent to ...

of the GDP of the United States
of the total wealth of the 500 richest people in the world
of the top 100 U.S. college endowments
of the top 200 U.S. executives’ total awarded compensation
of U.S. existing home sales
times the median U.S. household income

Latest News

Net Worth Summary

Private asset
Public asset
Misc. liabilities
Confidence rating:

The majority of Zhao's fortune is derived from her stake in Bloomage Biotechnology Corp, a publicly traded maker of medical skincare products.

She owns about 59% of the shares in Bloomage BioTech, according to the company's 2022 third-quarter report.

She also holds about a 7% stake in First Capital Securities, a Shenzhen-based provider of financial services. About two-fifths of the shares are pledged and removed from the calculation, according to a Nov. 4, 2022 filing.

Cash investments are based on an analysis of dividends, insider transactions, taxes and market performance.

Jiang Rui, a spokesperson for Bloomage BioTech, declined to comment on the net worth calculation.


Family: Unknown, No children

Zhou Yan has a bachelor's degree from East China Normal University. She completed an MBA in China between 2000 and 2002 at Peking University. Around the same time she also obtained an MBA from Fordham University in New York.

She joined the board of Shandong Freda Biopharmaceutic, later renamed Bloomage BioTech, in 2003 and was appointed chairman in 2019.

  • 1998 Bloomage Freda Biopharm is established.
  • 2003 Joins board of Shandong Freda Biopharmaceutic.
  • 2008 Becomes first company to receive licence for hyaluronic acid as supplement.
  • 2018 China becomes world's second biggest cosmetics market.